Combination Therapy May Increase Lesion Closure in PCV - Poll - MDSpire

Combination Therapy May Increase Lesion Closure in PCV

The combination of photodynamic therapy and intravitreal  aflibercept did not improve 1-year visual acuity outcomes compared with aflibercept monotherapy.

  • By

  • Andrea Surnit

  • May 13, 2026

  • 3 min

Share

Original Source(s)

Combination Therapy May Increase Lesion Closure in PCV

  • by Andrea Surnit

  • May 13, 2026

Related Content

GLP-1 Eye Effects Raise Questions

Authors describe both potential retinal benefits and possible rare optic nerve risks, while emphasizing that long-term ocular safety data remain limited as use expands.

Suspected Ocular Toxoplasmosis in Patients with ABCA4-Related Maculopathy

FDA Approves Lucentis Biosimilar Nufymco

Ranibizumab-leyk (Nufymco) is approved for all Lucentis indications.